Genelux Stock Quote GNLX - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.0485

Bid

2.00

Ask

2.05

Volume

152,142

1.95 Day's Range 2.205

1.60 52 Week Range 28.36

Market Cap

70.746M

Previous Close

2.18

Open

2.20

Last Trade

2.025

Last Trade Time

12:21:12

Financial Volume

$ 317,711

VWAP

2.0883

Average Volume (3m)

178,099

Shares Outstanding

34,535,471

Dividend Yield

PE Ratio

-2.48

Earnings Per Share (EPS)

-0.82

Revenue

170k

Net Profit

-28.3M

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac... Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.genelux.com

Headquarters

Wilmington, Delaware, USA

Founded

Genelux Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GNLX. The last closing price for Genelux was $2.18. Over the last year, Genelux shares have traded in a share price range of $ 1.60 to $ 28.36.

Genelux currently has 34,535,471 shares outstanding. The market capitalization of Genelux is $75.29 million. Genelux has a price to earnings ratio (PE ratio) of -2.48.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.5015	-19.6666666667	2.55	2.5673	1.95	160406	2.22751534	CS
4	-0.1315	-6.03211009174	2.18	3.11	1.95	210871	2.45426499	CS
12	0.1485	7.81578947368	1.9	3.11	1.6	178099	2.26360723	CS
26	-4.2315	-67.3805732484	6.28	6.5	1.6	201934	2.84763643	CS
52	-24.9015	-92.3988868275	26.95	28.36	1.6	168458	7.02694938	CS
156	-3.9515	-65.8583333333	6	40.98	1.6	152123	12.47854319	CS
260	-3.9515	-65.8583333333	6	40.98	1.6	152123	12.47854319	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OCTOEightco Holdings Inc	$ 3.748 (50.52%)	91.11M
ATGLAlpha Technology Group Limited	$ 2.15 (49.03%)	994.48k
INVZWInnoviz Technologies Ltd	$ 0.18 (45.69%)	11.02k
SBCSBC Medical Group Holdings Incorporated	$ 9.40 (41.78%)	1.32M
RZLVRezolve AI Ltd	$ 6.89 (40.04%)	1.37M
VTNRVertex Energy Inc	$ 0.1465 (-59.42%)	28.69M
CMCTCreative Media and Community Trust Corporation	$ 0.818301 (-47.71%)	1.99M
SFIXStitch Fix Inc	$ 2.395 (-36.13%)	11.37M
BNZIBanzai International Inc	$ 5.445 (-33.92%)	2.32M
SHOTWSafety Shot Inc	$ 0.23 (-28.13%)	8.8k
NVDANVIDIA Corporation	$ 123.40 (2.09%)	167.26M
CEROCERo Therapeutics Holdings Inc	$ 0.1001 (6.83%)	108.51M
MLGOMicroAlgo Inc	$ 0.2537 (17.35%)	94.79M
OCTOEightco Holdings Inc	$ 3.748 (50.52%)	91.11M
SQQQProShares UltraPro Short QQQ	$ 7.4799 (-2.22%)	76.06M